Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2793)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5690)
  2. Department of Medicine (5680)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (663)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (199)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (121)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (394)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5690)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts)
    Meeting Abstract

    Kondagunta, G. V.; Bacik, J.; Bajorin, D. F.; Reich, L.; Sheinfeld, J.; Bains, M.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Population pharmacokinetic (PK)-pharmacodynamic (PD) meta-analysis of sunitinib malate (SU11248) efficacy and tolerability endpoints in gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (MRCC) and solid tumor patients
    Meeting Abstract

    Houk, B. E.; Bello, C.; Garrett, M.; Poland, B.; Wagg, J.; Wada, R.; Motzer, R.; Rosen, L.; Demetri, G.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase I/II study of dose-dense sequential chemotherapy in renal impaired patients (Pts) with transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Galsky, M. D.; Mironov, S.; Scattergood, J.; Dobrzynski, D.; Mitra, N.; Boyle, M. G.; Bajorin, D. F.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of pulsatile high dose gefitinib and docetaxel in patients with an advanced solid tumor
    Meeting Abstract

    Fury, M. G.; Kris, M.; Solit, D.; Pfister, D. G.; Azzoli, C. G.; Henry, R.; Su, Y. B.; Rizvi, N.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Association of age, baseline characteristics, co-marbidity and toxicity in castrate metastatic prostate cancer patients (CMPC) treated with chemotherapy
    Meeting Abstract

    Fleming, M. T.; Beekman, K. W.; Warren, M.; Wilton, A.; Heller, G.; Scher, H.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Evaluation of plasma insulin-like growth factor binding protein 2 (IGFBP-2) as a biomarker for 17-allylamino-17-demethoxygeldanamycin (17-AAG) treatment of adult patients (pts) with advanced solid tumors
    Meeting Abstract

    Eiseman, J. L.; Guo, J.; Weinbaum, B.; Ramanathan, R. K.; Belani, C. P.; Solit, D. B.; Scher, H. I.; Ivy, S. P.; Zuhowski, E. G.; Egorin, M. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Optimal combined modality treatment improves outcome of locally advanced bladder cancer: Analysis of SWOG 8710
    Meeting Abstract

    Dotan, Z. A.; Bajorin, D. F.; Grossman, B. H.; Herr, H. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The multitargeted kinase inhibitor sunitinib malate (SU11248): Soluble protein biomarkers of pharmacodynamic activity in patients with metastatic renal cell cancer
    Meeting Abstract

    DePrimo, S.; Bello, C.; Smeraglia, J.; Shalinsky, D.; Freddo, J.; Baum, C.; Rini, R.; Michaelson, M.; Motzer, R.; Spinella, D.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • A synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer
    Meeting Abstract

    Daigneault, L.; Panchal, C.; Scher, H. I.; Slovin, S. F.; Rabbani, S.; Dulude, H.; Garde, S.; Ruiz, M.; Wu, J.; Hawkins, R.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: The impact of time
    Meeting Abstract

    Carver, B. S.; Motzer, R. J.; Bajorin, D.; Stasi, J.; Bosl, G. J.; Sheinfeld, J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save